Case Study and Debate: Curative Intent in Elderly and Frail
This session will review three cases highlighting challenging situations which arise in the management of patients that are elderly/frail: the role of surgery in these patients, deciding on which radiosensitizer to use (if any) in elderly/frail patients undergoing definitive RT, and lastly frail patients with locally advanced squamous cell carcinoma of the skin who may benefit from a neoadjuvant immunotherapy approach.
This meeting is designed to meet the interests of medical oncologists, radiation oncologists, surgeons, physicists, nurses, diagnostic radiologists, pathologists, radiation therapists, radiation dosimetrists, speech language pathologists/scientists, dentists, oral surgeons, swallowing and speech therapists, audiologists, physical therapists, scientists, immunologist and rehabilitation specialists.
Upon completion of this activity, participants should be able to do the following:
- Identify how to evaluate elderly/frail patients with head and neck cancer for potential surgery.
- Identify the nuances of the decision about when to add radiosensitizers versus accelerated radiation alone, versus standard fractionated radiation in the curative intent management of head and neck cancer in the elderly/frail population.
- Describe the role of neoadjuvant immunotherapy for locally advanced squamous cell carcinoma of the skin.
Susan McCammon, MD, is employed by the University of Alabama and has no financial relationships with a commercial interest.
Loren Mell, MD, is employed by the University of California, San Diego and has no financial relationships with a commercial interest.
Paul Loren Swiecicki, MD, is employed by the University of Michigan and has no financial relationships with a commercial interest.
All relevant relationships have been mitigated.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
- 1.00 AMA PRA Category 1 Credit™The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 Certificate of AttendanceThis activity was designated for 1.00 AMA PRA Category 1 Credit™.